These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 19813133)
1. Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors. Reid-Arndt SA; Yee A; Perry MC; Hsieh C J Psychosoc Oncol; 2009; 27(4):415-34. PubMed ID: 19813133 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer. Reid-Arndt SA; Hsieh C; Perry MC Psychooncology; 2010 May; 19(5):535-44. PubMed ID: 19472296 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526 [TBL] [Abstract][Full Text] [Related]
4. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337 [TBL] [Abstract][Full Text] [Related]
5. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304 [TBL] [Abstract][Full Text] [Related]
6. An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors. Cheung YT; Tan EH; Chan A Support Care Cancer; 2012 Jul; 20(7):1361-75. PubMed ID: 22476439 [TBL] [Abstract][Full Text] [Related]
7. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy? Player L; Mackenzie L; Willis K; Loh SY Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery. Reid-Arndt SA Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112 [TBL] [Abstract][Full Text] [Related]
9. Lifestyle factors associated with cognitive functioning in breast cancer survivors. Hartman SJ; Marinac CR; Natarajan L; Patterson RE Psychooncology; 2015 Jun; 24(6):669-75. PubMed ID: 25073541 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578 [TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Jung MS; Cimprich B Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143 [TBL] [Abstract][Full Text] [Related]
12. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response. Boykoff N; Moieni M; Subramanian SK J Cancer Surviv; 2009 Dec; 3(4):223-32. PubMed ID: 19760150 [TBL] [Abstract][Full Text] [Related]
13. Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial. Witlox L; Schagen SB; de Ruiter MB; Geerlings MI; Peeters PHM; Koevoets EW; van der Wall E; Stuiver M; Sonke G; Velthuis MJ; Palen JAMV; Jobsen JJ; May AM; Monninkhof EM BMJ Open; 2019 Jun; 9(6):e028117. PubMed ID: 31227537 [TBL] [Abstract][Full Text] [Related]
14. Does rurality affect quality of life following treatment for breast cancer? Reid-Arndt SA; Cox CR J Rural Health; 2010; 26(4):402-5. PubMed ID: 21029176 [TBL] [Abstract][Full Text] [Related]
15. The potential for neuropsychology to inform functional outcomes research with breast cancer survivors. Reid-Arndt SA NeuroRehabilitation; 2006; 21(1):51-64. PubMed ID: 16720938 [TBL] [Abstract][Full Text] [Related]
16. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315 [TBL] [Abstract][Full Text] [Related]
17. Cognitive functioning in breast cancer survivors: a controlled comparison. Jim HS; Donovan KA; Small BJ; Andrykowski MA; Munster PN; Jacobsen PB Cancer; 2009 Apr; 115(8):1776-83. PubMed ID: 19224550 [TBL] [Abstract][Full Text] [Related]
18. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410 [TBL] [Abstract][Full Text] [Related]
19. Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors. Kesler SR; Blayney DW JAMA Oncol; 2016 Feb; 2(2):185-92. PubMed ID: 26633037 [TBL] [Abstract][Full Text] [Related]
20. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]